Iskani rezultati za avtorja

1

Immunopathogenesis of multiple sclerosis od Racke, Michael K.

Izdano 2009

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
2

Challenges in Developing New Multiple Sclerosis Therapies od Racke, Michael K.

Izdano 2008

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
3

Natalizumab: Increased Vigilance is Required in Treating Patients with Multiple Sclerosis od Racke, Michael K., Stüve, Olaf

Izdano 2008

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
4

PPARs in Neuroinflammation od Racke, Michael K., Drew, Paul D.

Izdano 2008

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
5

Toll-Like Receptors in Multiple Sclerosis od Racke, Michael K., Drew, Paul D.

Izdano 2009

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
6

Care of persons with MS in clinical practice: Management by majority od Marrie, Ruth Ann, Racke, Michael K.

Izdano 2016

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
7

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration od Racke, Michael K., Newsome, Scott D.

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
8

Peroxisome proliferator-activated receptor-α agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis od Xu, Jihong, Racke, Michael K., Drew, Paul D.

Izdano 2007

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
9

PPAR-γ: Therapeutic Potential for Multiple Sclerosis od Drew, Paul D., Xu, Jihong, Racke, Michael K.

Izdano 2008

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
10

Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes od Racke, Michael K., Frohman, Elliot M., Frohman, Teresa

Izdano 2022

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
11

Th1 Versus Th17: Are T Cell Cytokines Relevant in Multiple Sclerosis? od Lovett-Racke, Amy E., Yang, Yuhong, Racke, Michael K.

Izdano 2010

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
12

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs od Yang, Yuhong, Lovett-Racke, Amy E., Racke, Michael K.

Izdano 2010

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
13

Multiple sclerosis: Five new things od Nicholas, Jacqueline A., Boster, Aaron L., Racke, Michael K.

Izdano 2013

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
14

miRNAs in Multiple Sclerosis: Regulating the Regulators od Guerau-de-Arellano, Mireia, Lovett-Racke, Amy E., Racke, Michael K.

Izdano 2010

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
15

First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks od Nicholas, Jacqueline Ann, Racke, Michael Karl, Imitola, Jamie, Boster, Aaron Lee

Izdano 2014

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
16

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis od Boster, Aaron, Bartoszek, Mary Pat, O’Connell, Colleen, Pitt, David, Racke, Michael

Izdano 2011

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
17

Analysis of TGF-β1 and TGF-β3 as Regulators of Encephalitogenic Th17 Cells: Implications for Multiple Sclerosis od Lee, Priscilla W., Yang, Yuhong, Racke, Michael K., Lovett-Racke, Amy E.

Izdano 2014

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
18

Changes in ganglioside antibody positivity rates during the COVID-19 pandemic od Racke, Michael K., Niles, Justin K., Lorenz, Raymond A., Kaufman, Harvey W.

Izdano 2022

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
19

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis od Yang, Yuhong, Gocke, Anne R., Lovett-Racke, Amy, Drew, Paul D., Racke, Michael K.

Izdano 2008

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
20

Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis od Stuart, Rodney, Lovett-Racke, Amy E., Frohman, Elliot M., Hawker, Kathleen, Racke, Michael K.

Izdano 2007

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:

Rezultati - Racke, Michael

Immunopathogenesis of multiple sclerosis od Racke, Michael K.

Challenges in Developing New Multiple Sclerosis Therapies od Racke, Michael K.

Natalizumab: Increased Vigilance is Required in Treating Patients with Multiple Sclerosis od Racke, Michael K., Stüve, Olaf

PPARs in Neuroinflammation od Racke, Michael K., Drew, Paul D.

Toll-Like Receptors in Multiple Sclerosis od Racke, Michael K., Drew, Paul D.

Care of persons with MS in clinical practice: Management by majority od Marrie, Ruth Ann, Racke, Michael K.

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration od Racke, Michael K., Newsome, Scott D.

Peroxisome proliferator-activated receptor-α agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis od Xu, Jihong, Racke, Michael K., Drew, Paul D.

PPAR-γ: Therapeutic Potential for Multiple Sclerosis od Drew, Paul D., Xu, Jihong, Racke, Michael K.

Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes od Racke, Michael K., Frohman, Elliot M., Frohman, Teresa

Th1 Versus Th17: Are T Cell Cytokines Relevant in Multiple Sclerosis? od Lovett-Racke, Amy E., Yang, Yuhong, Racke, Michael K.

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs od Yang, Yuhong, Lovett-Racke, Amy E., Racke, Michael K.

Multiple sclerosis: Five new things od Nicholas, Jacqueline A., Boster, Aaron L., Racke, Michael K.

miRNAs in Multiple Sclerosis: Regulating the Regulators od Guerau-de-Arellano, Mireia, Lovett-Racke, Amy E., Racke, Michael K.

First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks od Nicholas, Jacqueline Ann, Racke, Michael Karl, Imitola, Jamie, Boster, Aaron Lee

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis od Boster, Aaron, Bartoszek, Mary Pat, O’Connell, Colleen, Pitt, David, Racke, Michael

Analysis of TGF-β1 and TGF-β3 as Regulators of Encephalitogenic Th17 Cells: Implications for Multiple Sclerosis od Lee, Priscilla W., Yang, Yuhong, Racke, Michael K., Lovett-Racke, Amy E.

Changes in ganglioside antibody positivity rates during the COVID-19 pandemic od Racke, Michael K., Niles, Justin K., Lorenz, Raymond A., Kaufman, Harvey W.

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis od Yang, Yuhong, Gocke, Anne R., Lovett-Racke, Amy, Drew, Paul D., Racke, Michael K.

Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis od Stuart, Rodney, Lovett-Racke, Amy E., Frohman, Elliot M., Hawker, Kathleen, Racke, Michael K.

Iskalna orodja: